Failing to improve overall survival because post-protocol survival is long: fact, myth, excuse or improper study design?
Medical Oncology Branch, National Cancer Institute, National Institutes of Health, 10 Center Dr. 10/12N226, Bethesda, MD, 20892, USA, vinayak.prasad@nih.gov.
Vinay
V
Prasad
Andrae
A
Vandross
D002985:Clinical Protocols / Q000592:standards*; D002986:Clinical Trials as Topic / Q000592:standards*; D006801:Humans; D009369:Neoplasms / Q000401:mortality* / Q000628:therapy; D011379:Prognosis; D012107:Research Design / Q000592:standards*; D015996:Survival Rate